Detected ·
Switchpoint Bio
€4.75MPre-Seed
Helsinki/Cambridge TechBio startup Switchpoint Bio raised EUR 4.75M (USD 5.3M) in a pre-seed round, including a USD 5M investment from Treehouse Delmar Investments, to advance its blood-based epigenomic AI platform for drug development.
- Website
- www.switchpointbio.com
- linkedin.com/company/106696756
- Amount
- €4 750 000 EUR
- Stage
- Pre-Seed
- Event
- Funding round
- Detected
- 2026-11-11 16:11:10 UTC
- Signal ID
- e03b2d35-bbee-442c-975e-4eb58d6cba87
As the API returns it
{
"id": "e03b2d35-bbee-442c-975e-4eb58d6cba87",
"created_at": "2026-11-11T16:11:10.989107Z",
"company_name": "Switchpoint Bio",
"company_website_url": "www.switchpointbio.com",
"company_linkedin_url": "https://www.linkedin.com/company/106696756",
"event_type": "funding",
"funding_amount": 4750000,
"funding_currency": "EUR",
"funding_stage": "pre_seed",
"message": "*Helsinki/Cambridge TechBio startup Switchpoint Bio raised EUR 4.75M (USD 5.3M) in a pre-seed round, including a USD 5M investment from Treehouse Delmar Investments, to advance its blood-based epigenomic AI platform for drug development.*"
}